Healthcare / Medical DevicesUpdated 2026-05-10 22:07 UTC

EBR/IBAB stock hub

EBR/IBAB has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

EBR/IBABis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

437.5M

Euronext Brussels

Market data

Live price

Current market quote for this ticker.

Current price

EBR/IBAB

In the news

Latest news · EBR/IBAB

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E12.1

P25 n/aP50 n/aP75 n/a

Trailing P/E34.9

P25 n/aP50 n/aP75 n/a

ROEn/a

P25 n/aP50 n/aP75 n/a

ROIC24.7

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All EBR/IBAB market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

174

Groups with data

Currency

EUR

Showing 174 of 174 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Belgium
Country code	BE
Employees	2,300
Employees Change	13%
Employees Change Percent	0.57
Enterprise value	EUR 468.6M
Exchange	Euronext Brussels
Financial currency	EUR
First seen	2026-05-10
Industry	Medical Devices
Isin	BE0003766806
Last refreshed	2026-05-10
Market cap	EUR 437.5M
Price	EUR 15
Price currency	EUR
Rev Per Employee	295,333.33x
Sector	Healthcare
Sic	3845
Symbol	ebr/IBAB
Website	https://www.iba-worldwide.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	2.9%
EV Earnings	36.9x
EV/EBIT	17.1x
EV/EBITDA	15.13x
EV/Sales	0.76x
Forward P/E	12.14x
P/E ratio	34.88x
P/S ratio	0.71x
PE Ratio10 Y	51.47x
PE Ratio3 Y	30.43x
PE Ratio5 Y	32.44x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	4.42%
EBITDA Margin	4.99%
Gross margin	32.18%
Gross Profit	EUR 199.6M
Gross Profit Growth	7.84%
Gross Profit Growth Q	13.98%
Gross Profit Growth3 Y	7.82%
Gross Profit Growth5 Y	12.82%
Net Income	EUR 12.7M
Net Income Growth	37.25%
Net Income Growth Q	-21.76%
Net Income Growth Years	2%
Net Income Growth3 Y	17.39%
Pretax Margin	3.03%
Profit Margin	2.05%
Profit Per Employee	EUR 6,048
Profitable Years	2
ROIC	24.66

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-7.61%
Cagr15y	5.03%
Cagr1y	35.86%
Cagr20y	1.12%
Cagr3y	-1.07%
Cagr5y	-1.58%
Div CAGR10	-16.46%
Div CAGR3	4.55%
Div CAGR5	3.71%
EPS Growth	37.03
EPS Growth Years	2
EPS Growth3 Y	16.89
Revenue Growth	24.5x
Revenue Growth Q	8.09x
Revenue Growth Quarters	8x
Revenue Growth Years	8x
Revenue Growth3 Y	10.02x
Revenue Growth5 Y	10.84x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
WACC	10.81

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.17%
Dividend Growth	41.18%
Dividend Growth Years	1%
Dividend per share	EUR 0.25
Dividend Years	6
Dividend Yield	1.67%
Ex Div Date	2025-06-18
Last Dividend	EUR 0.17
Payout Frequency	Annual

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-54.66%
1Y total return	35.83%
200-day SMA	12.68
3Y total return	-3.19%
50-day SMA	14.03
50-day SMA vs 200-day SMA	50over200
5Y total return	-7.64%
All Time High	56.94
All Time High Change	-73.66%
All Time High Date	2017-05-08
All Time Low	1.96
All Time Low Change	664.53%
All Time Low Date	2003-04-18
ATR	0.45
Beta	1.19
Beta1y	0.76
Beta2y	0.83
Ch YTD	16.1
High	15
High52	15.9
High52 Date	2026-02-20
High52ch	-5.66%
Low	14.66
Low52	9.9
Low52 Date	2025-11-19
Low52ch	51.52%
Ma50ch	6.94%
Price vs 200-day SMA	18.3%
RSI	65.84
RSI Monthly	56.96
RSI Weekly	59.88
Sharpe ratio	0.89x
Sortino ratio	1.69
Total Return	1.49%
Tr YTD	16.1
Tr15y	108.72%
Tr1m	21.95%
Tr1w	8.7%
Tr3m	-1.06%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR 27.4M
Operating Income Growth	-28.08
Operating Income Growth Q	-34.32
Operating Income Growth3 Y	2.64
Operating margin	4.42

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	19,439,109%
Shares Institutions	32.78%
Shares Out	29,169,058
Shares Yo Y	0.17%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	35,856.75x
Ch10y	-58.45
Ch15y	87.5
Ch1m	21.95
Ch1w	8.7
Ch1y	33.93
Ch20y	10.29
Ch3m	-1.06
Ch3y	-6.25
Ch5y	-12.08
Ch6m	41.51
Change	0.67%
Change From Open	0.67
Close	14.9
Days Gap	0
Depreciation Amortization	3,573,000
Dollar Volume	658,650
Earnings Date	2026-04-30
EBIT	EUR 27.4M
EBITDA	EUR 31M
EPS	EUR 0.43
F Score	2
Fiscal Year End	December
Founded	1,986
Income Tax	EUR 6.1M
Is Primary Listing	1
Last Earnings Date	2026-04-30
Last Report Date	2025-12-31
Last Split Date	1999-06-11
Last Split Type	Forward
Lynch Fair Value	EUR 7.48
Lynch Upside	-50.15
Ma150	13.05
Ma150ch	14.93%
Ma20	14.03
Ma20ch	6.9%
Next Earnings Date	2026-05-21
Open	14.9
Payment Date	2025-07-01
Position In Range	100
Price Date	2026-05-08
Price EBITDA	EUR 14.13
Relative Volume	1.27x
Revenue	620,200,000x
Tax By Revenue	0.98x
Tax Rate	32.45%
Tr20y	24.98%
Tr6m	41.51%
Volume	43,910

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

EBR/IBAB dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+1.7%

$0.25 annual per share

Payout ratio

n/a

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+3.7%

1 consecutive years of growth

Total shareholder yield

+1.5%

Next ex-dividend date: 2025-06-18

Performance

EBR/IBAB stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns EBR/IBAB?

Insider, institutional, and short-interest positioning.

Institutional ownership

+32.8%

Share of float held by funds and institutions

Insider ownership

n/a

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+0.2%

Negative means the company is buying back shares.

Technical

EBR/IBAB momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

65.8

Neutral momentum band

Price vs 200-day MA

+18.3%

50/200-day relationship not available

Beta (5Y)

1.19

Moves roughly with the market

Sharpe ratio

0.89

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About EBR/IBAB

Hub-level FAQ points readers to the deeper analysis pages.

What is the current ebr/IBAB stock rating?

ebr/IBAB is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full ebr/IBAB analysis?

The full report lives at /stocks/ebr/IBAB/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for ebr/IBAB?

The latest report frames ebr/IBAB around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the ebr/IBAB page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.